These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6004972)

  • 1. [A study of a virulent strain of F. tularensis in tissue culture in vitro].
    Makarenko IG
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Nov; 43(11):76-80. PubMed ID: 6004972
    [No Abstract]   [Full Text] [Related]  

  • 2. [COMPARATIVE STUDY OF VIRULENT AND VACCINAL STRAINS OF F. TULARENSIS IN HUMAN EMBRYONAL TISSUE CULTURE].
    FEDOTOVA IuM
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Dec; 40():84-8. PubMed ID: 14151791
    [No Abstract]   [Full Text] [Related]  

  • 3. [The cytochemistry of cultures of fibroblasts infected with virulent and vaccinal strains of the agent of tularemia].
    Makarenko IG
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Jul; 44(7):61-4. PubMed ID: 5617053
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protective reaction of cells of a culture of fibroblasts infected with tularemia bacteria].
    Makarenko IG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):77-80. PubMed ID: 5690852
    [No Abstract]   [Full Text] [Related]  

  • 5. [Karyometric study of the reaction of cells in monolayer tissue culture of human embryo to infection with virulent bacterial strains].
    Khesin IaE; Ginsburg NN; Fedotova IuM
    Dokl Akad Nauk SSSR; 1966 Nov; 171(3):725-7. PubMed ID: 4968845
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative proteomic profiling of culture filtrate proteins of less and highly virulent Francisella tularensis strains.
    Konecna K; Hernychova L; Reichelova M; Lenco J; Klimentova J; Stulik J; Macela A; Alefantis T; Delvecchio VG
    Proteomics; 2010 Dec; 10(24):4501-11. PubMed ID: 21136602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Substrate Usage and Metabolic Fluxes in
    Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K
    Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characterization of the recombinant strain Francisella tularensis R1A].
    Kislichkin NN; Kormilitsyna MI; Meshcheriakova IS
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (3):3-6. PubMed ID: 9700870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-Mediated Mechanisms Controlling Replication of
    Eneslätt K; Golovliov I; Rydén P; Sjöstedt A
    Front Cell Infect Microbiol; 2018; 8():27. PubMed ID: 29468144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
    Rees DG; Hartley MG; Green M; Lukaszewski RA; Griffin KF; Atkins HS; Lyons R; Krieg AM; Titball RW
    Microb Pathog; 2013 Oct; 63():16-8. PubMed ID: 23707360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
    Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence of Francisella spp. in chicken embryos.
    Nix EB; Cheung KK; Wang D; Zhang N; Burke RD; Nano FE
    Infect Immun; 2006 Aug; 74(8):4809-16. PubMed ID: 16861669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 17. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.
    Johansson A; Urich SK; Chu MC; Sjöstedt A; Tärnvik A
    Scand J Infect Dis; 2002; 34(5):327-30. PubMed ID: 12069013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a wild-type strain of Francisella tularensis isolated from a cat.
    Inzana TJ; Glindemann GE; Snider G; Gardner S; Crofton L; Byrne B; Harper J
    J Vet Diagn Invest; 2004 Sep; 16(5):374-81. PubMed ID: 15460318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.